Sarah J Allgood

Dr. Sarah J Allgood


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
NLNoah Lechtzin
Noah Lechtzin
NMNicole Mayer-Hamblett
Nicole Mayer-Hamblett
NWNatalie E. West
Natalie E. West
SASarah J Allgood
Sarah J Allgood
EWEllen Wilhelm
Ellen Wilhelm
CGChristopher H. Goss
Christopher H. Goss
Rationale: Individuals with cystic fibrosis (CF) experience frequent acute pulmonary exacerbations, which lead to decreased lung function and reduced quality of life. Objectives: The goal of this study was to determine if an intervention directed toward early detection of pulmonary exacerbations using home spirometry and symptom monitoring would result in slower decline in lung function than in control subjects. Methods: We conducted a multicenter, randomized trial at 14 CF centers with subjects at least 14 years old. The early intervention arm subjects measured home spirometry and symptoms electronically twice per week. Sites were notified if a participant met criteria for an exacerbation and contacted participants to determine if treatment for acute exacerbation was required. Participants in the usual care arm were seen every 3 months and were asked to contact the site if they were concerned about worsening pulmonary symptoms. Measurements and Main Results: The primary outcome was the 52-week change in FEV1. Secondary outcomes included time to first exacerbation and subsequent exacerbation, quality of life, and change in weight. A total of 267 patients were randomized, and the study arms were well matched at baseline. There was no significant difference between study arms in 52-week mean change in FEV1 slope (mean slope difference, 0.00 L, 95% confidence interval, −0.07 to 0.07; P = 0.99). The early intervention arm subjects detected exacerbations more frequently than usual care arm subjects (time to first exacerbation hazard ratio, 1.45; 95% confidence interval, 1.09 to 1.93; P = 0.01). Adverse events were not significantly different between treatment arms. Conclusions: An intervention of home monitoring among patients with CF was able to detect more exacerbations than usual care, but this did not result in slower decline in lung function. Clinical trial registered with www.clinicaltrials.gov (NCT01104402).

1 April 2017 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
GHGina Hong
Gina Hong
HMHeather B. Miller
Heather B. Miller
SASarah J Allgood
Sarah J Allgood
RLRichard Lee
Richard Lee
NLNoah Lechtzin
Noah Lechtzin
SZSean Zhang
Sean Zhang
The prevalence of fungi in the respiratory tracts of cystic fibrosis (CF) patients has risen. However, fungal surveillance is not routinely performed in most clinical centers in the United States, which may lead to an underestimation of the true prevalence of the problem. We conducted a prospective study comparing the rates of detection for clinically important fungi (CIF), defined as Aspergillus , Scedosporium , and Trichosporon species and Exophiala dermatitidis , in CF sputa using standard bacterial and selective fungal culture media, including Sabouraud dextrose agar with gentamicin (SDA), inhibitory mold agar (IMA), and brain heart infusion (BHI) agar with chloramphenicol and gentamicin. We described the prevalence of these fungi in an adult CF population. A total of 487 CF respiratory samples were collected from 211 unique participants. CIF were detected in 184 (37.8%) samples. Only 26.1% of CIF-positive samples were detected in bacterial culture medium, whereas greater rates of detection for fungi were found in IMA (65.8%; P < 0.001), in SDA (at 30°C, 64.7%; P = 0.005), and in BHI agar (63.0%; P = 0.001). The prevalences of Aspergillus and Scedosporium species were 40.8% and 5.2%, respectively, which are greater than the nationally reported prevalence numbers of 20.4% and 1.9%. Selective fungal culture media and longer incubation periods yielded higher rates of detection for CIF in CF sputum samples compared with that detected in bacterial culture medium, resulting in an underdetection of fungi by bacterial culture alone. The prevalence of fungi in CF may be better estimated by using selective fungal culture media, and this may translate to important clinical decisions.


14 October 2016 in Clinics in Chest Medicine
Verified
Journal Article
Closed access
SSSarina Sahetya
Sarina Sahetya
SASarah J Allgood
Sarah J Allgood
PGPeter C. Gay
Peter C. Gay
NLNoah Lechtzin
Noah Lechtzin

1 November 2016 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
NLNoah Lechtzin
Noah Lechtzin
SASarah J Allgood
Sarah J Allgood
GHGina Hong
Gina Hong
KRKristin Riekert
Kristin Riekert
JHJennifer A. Haythornthwaite
Jennifer A. Haythornthwaite
MYMyron Yaster
Myron Yaster

8 August 2021 in Journal of Clinical Nursing
Verified
Journal Article
Open access
PDF file
SASarah J Allgood
Sarah J Allgood
JPJessica Peters
Jessica Peters
ABAndrew Benson
Andrew Benson
CMCarol Maragos
Carol Maragos
KMKimberly McIltrot
Kimberly McIltrot
VPVinciya Pandian
Vinciya Pandian
Click on the article title to read more.